OLIVIA STALA: Open Payments
NPI 1457071615 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 20 payments from 12 companies in 2025. Trend: 2023 $1,509 · 2024 $1,308 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $73 |
| Janssen Biotech, Inc. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Daiichi Sankyo Inc. | 2 | $54 |
| Aveo Pharmaceuticals, Inc. | 1 | $36 |
| ABBVIE INC. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: ENHERTU, DATROWAY, SARCLISA, RYBREVANT, FOTIVDA, ELAHERE, Vyloy, Onivyde.
Industry payments across FL — which companies pay providers there.
